中国经济发达地区代谢综合征患病率的十年趋势。

IF 3 Q2 ENDOCRINOLOGY & METABOLISM Journal of the Endocrine Society Pub Date : 2024-07-03 eCollection Date: 2024-07-01 DOI:10.1210/jendso/bvae128
Tianxing Feng, Jiali Zheng, Xiaoxiao Wang, Yilei Wang, Ping Shen, Beili Zhu, Huiyan Zhao, Li Zhao, Yaqing Xu
{"title":"中国经济发达地区代谢综合征患病率的十年趋势。","authors":"Tianxing Feng, Jiali Zheng, Xiaoxiao Wang, Yilei Wang, Ping Shen, Beili Zhu, Huiyan Zhao, Li Zhao, Yaqing Xu","doi":"10.1210/jendso/bvae128","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To estimate decadal trends in the prevalence of metabolic syndrome (MetS) in economically developed regions in China and its association with city economic levels.</p><p><strong>Methods: </strong>Using a comprehensive Chinese healthcare database, repeated cross-sectional studies were conducted on adults who had annual health check-ups from 2012 to 2021 in 4 economically developed cities. MetS was defined by the criteria of the Chinese Diabetes Society in 2013. The crude prevalence of MetS adjusted for sex and age was reported. The association between prevalence, calendar year, and city gross domestic product (GDP) per capita was analyzed by regression model.</p><p><strong>Results: </strong>158 274 participants aged 18 years and older were included. The unadjusted prevalence of MetS increased from 15.5% (95% CI: 14.2%-16.8%) to 20.0% (95% CI: 19.5%-20.5%) from 2012 to 2021. The adjusted overall prevalence has increased steadily from 12.8% to 20.8% after controlling age and sex (<i>P</i> < .001). Male and older age groups had a higher MetS prevalence. In the regression model of the association between the MetS prevalence, calendar year, and city GDP per capita, calendar year had a positive association with the prevalence (<i>P</i> < .001, 95% CI: 0.648-1.954) and city GDP per capita had a negative association (<i>P</i> = .030, 95% CI: -0.136 to -0.007).</p><p><strong>Conclusion: </strong>The MetS prevalence increased steadily in the economically developed regions in China among the health check-up population during 2012-2021. The MetS prevalence is shown to be negatively associated with GDP per capita in the study population.</p>","PeriodicalId":17334,"journal":{"name":"Journal of the Endocrine Society","volume":"8 8","pages":"bvae128"},"PeriodicalIF":3.0000,"publicationDate":"2024-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11252499/pdf/","citationCount":"0","resultStr":"{\"title\":\"Decadal Trends in the Prevalence of Metabolic Syndrome in Economically Developed Regions in China.\",\"authors\":\"Tianxing Feng, Jiali Zheng, Xiaoxiao Wang, Yilei Wang, Ping Shen, Beili Zhu, Huiyan Zhao, Li Zhao, Yaqing Xu\",\"doi\":\"10.1210/jendso/bvae128\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To estimate decadal trends in the prevalence of metabolic syndrome (MetS) in economically developed regions in China and its association with city economic levels.</p><p><strong>Methods: </strong>Using a comprehensive Chinese healthcare database, repeated cross-sectional studies were conducted on adults who had annual health check-ups from 2012 to 2021 in 4 economically developed cities. MetS was defined by the criteria of the Chinese Diabetes Society in 2013. The crude prevalence of MetS adjusted for sex and age was reported. The association between prevalence, calendar year, and city gross domestic product (GDP) per capita was analyzed by regression model.</p><p><strong>Results: </strong>158 274 participants aged 18 years and older were included. The unadjusted prevalence of MetS increased from 15.5% (95% CI: 14.2%-16.8%) to 20.0% (95% CI: 19.5%-20.5%) from 2012 to 2021. The adjusted overall prevalence has increased steadily from 12.8% to 20.8% after controlling age and sex (<i>P</i> < .001). Male and older age groups had a higher MetS prevalence. In the regression model of the association between the MetS prevalence, calendar year, and city GDP per capita, calendar year had a positive association with the prevalence (<i>P</i> < .001, 95% CI: 0.648-1.954) and city GDP per capita had a negative association (<i>P</i> = .030, 95% CI: -0.136 to -0.007).</p><p><strong>Conclusion: </strong>The MetS prevalence increased steadily in the economically developed regions in China among the health check-up population during 2012-2021. The MetS prevalence is shown to be negatively associated with GDP per capita in the study population.</p>\",\"PeriodicalId\":17334,\"journal\":{\"name\":\"Journal of the Endocrine Society\",\"volume\":\"8 8\",\"pages\":\"bvae128\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2024-07-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11252499/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the Endocrine Society\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1210/jendso/bvae128\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/7/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Endocrine Society","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1210/jendso/bvae128","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

目的估算中国经济发达地区代谢综合征(MetS)患病率的十年变化趋势及其与城市经济水平的关系:方法:利用中国医疗保健综合数据库,对 4 个经济发达城市 2012 年至 2021 年期间每年进行健康体检的成年人进行重复横断面研究。MetS根据中华医学会糖尿病学分会2013年的标准进行定义。报告了经性别和年龄调整后的 MetS 粗患病率。通过回归模型分析了患病率、日历年份和城市人均国内生产总值(GDP)之间的关系:共纳入 158 274 名 18 岁及以上的参与者。未经调整的 MetS 患病率从 2012 年的 15.5%(95% CI:14.2%-16.8%)增至 20.0%(95% CI:19.5%-20.5%)。在控制年龄和性别后,调整后的总体患病率从 12.8% 稳步上升至 20.8%(P < .001)。男性和老年组的 MetS 患病率更高。在 MetS 患病率、日历年和城市人均 GDP 之间关系的回归模型中,日历年与患病率呈正相关(P < .001,95% CI:0.648-1.954),城市人均 GDP 呈负相关(P = .030,95% CI:-0.136 至 -0.007):结论:2012-2021年间,中国经济发达地区健康体检人群的MetS患病率稳步上升。结论:2012-2021年期间,中国经济发达地区的健康体检人群中,MetS患病率稳步上升,研究显示,MetS患病率与人均GDP呈负相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Decadal Trends in the Prevalence of Metabolic Syndrome in Economically Developed Regions in China.

Objective: To estimate decadal trends in the prevalence of metabolic syndrome (MetS) in economically developed regions in China and its association with city economic levels.

Methods: Using a comprehensive Chinese healthcare database, repeated cross-sectional studies were conducted on adults who had annual health check-ups from 2012 to 2021 in 4 economically developed cities. MetS was defined by the criteria of the Chinese Diabetes Society in 2013. The crude prevalence of MetS adjusted for sex and age was reported. The association between prevalence, calendar year, and city gross domestic product (GDP) per capita was analyzed by regression model.

Results: 158 274 participants aged 18 years and older were included. The unadjusted prevalence of MetS increased from 15.5% (95% CI: 14.2%-16.8%) to 20.0% (95% CI: 19.5%-20.5%) from 2012 to 2021. The adjusted overall prevalence has increased steadily from 12.8% to 20.8% after controlling age and sex (P < .001). Male and older age groups had a higher MetS prevalence. In the regression model of the association between the MetS prevalence, calendar year, and city GDP per capita, calendar year had a positive association with the prevalence (P < .001, 95% CI: 0.648-1.954) and city GDP per capita had a negative association (P = .030, 95% CI: -0.136 to -0.007).

Conclusion: The MetS prevalence increased steadily in the economically developed regions in China among the health check-up population during 2012-2021. The MetS prevalence is shown to be negatively associated with GDP per capita in the study population.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of the Endocrine Society
Journal of the Endocrine Society Medicine-Endocrinology, Diabetes and Metabolism
CiteScore
5.50
自引率
0.00%
发文量
2039
审稿时长
9 weeks
期刊最新文献
A Stronger IMPACT on Career Development for Early- and Mid-career Faculty. Blood Pressure Decreases in Overweight Elderly Individuals on Vitamin D: A Randomized Trial. Aromatase Inhibitor Monotherapy to Augment Height in Boys: Does It Work and Is It Safe? Efficacy of Tocilizumab in Refractory Graves Orbitopathy From Real-World Clinical Practice: An Observational Study. Sexual Dimorphism in the Immunometabolic Role of Gpr183 in Mice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1